GSK Receives FDA Approval of Arnuity Ellipta for Asthma in Children From 5 Years of Age

London, UK 21 May 2018 --GSK today announced it has received approval from the US Food and Drug Administration (FDA) for the use of Arnuity Ellipta (fluticasone furoate) a once-daily inhaled corticosteroid (ICS) medicine for the maintenance...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news